AHA/ASA guideline recommendations for prevention of stroke in women oral contraceptives

Jump to: navigation, search

Stroke Main page

Patient Information




Hemorrhagic stroke
Ischemic stroke

Differential Diagnosis

Epidemiology and Demographics


NIH stroke scale
Glasgow coma scale

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S [2]

2014 AHA/ASA Guideline Recommendations for Prevention of Stroke in Women (DO NOT EDIT)[1]

Class III (Harm)
"1. OCs may be harmful in women with additional risk factors (eg, cigarette smoking, prior thromboembolic events) (Level of Evidence: B) "
"2. Routine screening for prothrombotic mutations before initiation of hormonal contraception is not useful. (Level of Evidence: A) "
Class I
" Measurement of BP before initiation of hormonal contraception is recommended. (Level of Evidence: B) "
Class IIb
" Among OC users, aggressive therapy of stroke risk factors may be reasonable. (Level of Evidence: C)"


  1. Bushnell C, McCullough LD, Awad IA, Chireau MV, Fedder WN, Furie KL; et al. (2014). "Guidelines for the Prevention of Stroke in Women: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association". Stroke. doi:10.1161/01.str.0000442009.06663.48. PMID 24503673.